D
Assembly Biosciences, Inc.
ASMB
$9.08
$0.627.33%
D
Sell
3/5/2025Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 3/5/2025 due to an increase in the valuation index and volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 3/5/2025 due to an increase in the valuation index and volatility index.
E
Sell
2/18/2025Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 2/18/2025 due to a decline in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 2/18/2025 due to a decline in the volatility index and total return index.
D
Sell
1/28/2025Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 1/28/2025 due to an increase in the volatility index and valuation index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 1/28/2025 due to an increase in the volatility index and valuation index.
E
Sell
1/10/2025Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 1/10/2025 due to a decline in the valuation index and volatility index.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 1/10/2025 due to a decline in the valuation index and volatility index.
D
Sell
7/18/2024Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 7/18/2024 due to an increase in the volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 7/18/2024 due to an increase in the volatility index.
E
Sell
7/3/2024Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 7/3/2024 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.03 to 0.04, and the quick ratio declined from 3.33 to 2.92.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 7/3/2024 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.03 to 0.04, and the quick ratio declined from 3.33 to 2.92.
D
Sell
4/25/2024Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 4/25/2024 due to an increase in the total return index and volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 4/25/2024 due to an increase in the total return index and volatility index.
E
Sell
3/28/2024Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 3/28/2024 due to a decline in the volatility index.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 3/28/2024 due to a decline in the volatility index.
D
Sell
3/18/2024Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 3/18/2024 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$3.8797 to -$3.2919, and EBIT increased 13.95% from -$17.49M to -$15.05M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 3/18/2024 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$3.8797 to -$3.2919, and EBIT increased 13.95% from -$17.49M to -$15.05M.
E
Sell
3/14/2023Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 03/14/2023.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 7.83 to 7.11.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 7.83 to 7.11.
D
Sell
10/5/2022Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 10/5/2022 due to a decline in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 10/5/2022 due to a decline in the volatility index and total return index.
D
Sell
9/19/2022Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 9/19/2022 due to an increase in the volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 9/19/2022 due to an increase in the volatility index.
D
Sell
8/30/2022Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 8/30/2022 due to a decline in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 8/30/2022 due to a decline in the volatility index and total return index.
D
Sell
8/12/2022Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 8/12/2022 due to a noticeable increase in the growth index, total return index and volatility index. Operating cash flow increased 34.97% from -$27.5M to -$17.89M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 8/12/2022 due to a noticeable increase in the growth index, total return index and volatility index. Operating cash flow increased 34.97% from -$27.5M to -$17.89M.
D
Sell
7/5/2022Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 7/5/2022 due to an increase in the total return index and volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 7/5/2022 due to an increase in the total return index and volatility index.
E
Sell
6/17/2022Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 6/17/2022 due to a decline in the volatility index and valuation index.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 6/17/2022 due to a decline in the volatility index and valuation index.
D
Sell
6/1/2022Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 6/1/2022 due to an increase in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 6/1/2022 due to an increase in the volatility index and total return index.
E
Sell
5/16/2022Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 5/16/2022 due to a decline in the solvency index and volatility index.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 5/16/2022 due to a decline in the solvency index and volatility index.
D
Sell
5/4/2022Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 5/4/2022 due to an increase in the volatility index, total return index and valuation index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 5/4/2022 due to an increase in the volatility index, total return index and valuation index.
E
Sell
4/18/2022Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 4/18/2022 due to a decline in the volatility index and valuation index.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 4/18/2022 due to a decline in the volatility index and valuation index.
D
Sell
3/22/2022Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 3/22/2022 due to an increase in the growth index, volatility index and valuation index. EBIT increased 4.39% from -$18.88M to -$18.05M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D- from E+ on 3/22/2022 due to an increase in the growth index, volatility index and valuation index. EBIT increased 4.39% from -$18.88M to -$18.05M.
E
Sell
11/8/2021Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the growth index and solvency index. The quick ratio declined from 14.33 to 12.17.
Assembly Biosciences, Inc. (ASMB) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the growth index and solvency index. The quick ratio declined from 14.33 to 12.17.
D
Sell
10/20/2021Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 10/20/2021 due to a decline in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 10/20/2021 due to a decline in the volatility index and total return index.
D
Sell
10/4/2021Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 10/4/2021 due to an increase in the volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 10/4/2021 due to an increase in the volatility index.
D
Sell
9/16/2021Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 9/16/2021 due to a decline in the volatility index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 9/16/2021 due to a decline in the volatility index.
D
Sell
8/27/2021Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 8/27/2021 due to an increase in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 8/27/2021 due to an increase in the volatility index and total return index.
D
Sell
8/10/2021Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 8/10/2021 due to a decline in the solvency index and volatility index. The quick ratio declined from 14.84 to 14.33.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 8/10/2021 due to a decline in the solvency index and volatility index. The quick ratio declined from 14.84 to 14.33.
D
Sell
7/23/2021Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 7/23/2021 due to an increase in the volatility index and total return index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 7/23/2021 due to an increase in the volatility index and total return index.
D
Sell
7/6/2021Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 7/6/2021 due to a decline in the volatility index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 7/6/2021 due to a decline in the volatility index.
D
Sell
6/17/2021Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 6/17/2021 due to an increase in the volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 6/17/2021 due to an increase in the volatility index.
D
Sell
5/28/2021Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 5/28/2021 due to a decline in the volatility index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 5/28/2021 due to a decline in the volatility index.
D
Sell
5/12/2021Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 5/12/2021 due to an increase in the growth index, volatility index and valuation index. Earnings per share increased from -$1.1028 to -$0.6855, and EBIT increased 26.51% from -$35.66M to -$26.21M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 5/12/2021 due to an increase in the growth index, volatility index and valuation index. Earnings per share increased from -$1.1028 to -$0.6855, and EBIT increased 26.51% from -$35.66M to -$26.21M.
D
Sell
12/8/2020Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 12/8/2020 due to a major decline in the growth index, total return index and volatility index. EBIT declined 161.09% from $6.58M to -$4.02M, earnings per share declined from $0.19 to -$0.0943, and total revenue declined 12.1% from $39.38M to $34.61M.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 12/8/2020 due to a major decline in the growth index, total return index and volatility index. EBIT declined 161.09% from $6.58M to -$4.02M, earnings per share declined from $0.19 to -$0.0943, and total revenue declined 12.1% from $39.38M to $34.61M.
D
Sell
9/10/2020Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D from D+ on 9/10/2020 due to a decline in the volatility index, total return index and valuation index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D from D+ on 9/10/2020 due to a decline in the volatility index, total return index and valuation index.
D
Sell
7/8/2020Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D+ from D on 7/8/2020 due to an increase in the total return index, solvency index and volatility index. The quick ratio increased from 11.35 to 11.93.
Assembly Biosciences, Inc. (ASMB) was upgraded to D+ from D on 7/8/2020 due to an increase in the total return index, solvency index and volatility index. The quick ratio increased from 11.35 to 11.93.
D
Sell
3/6/2020Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 3/6/2020 due to a noticeable increase in the growth index, efficiency index and solvency index. Total capital increased 68.39% from $169.54M to $285.49M, the quick ratio increased from 7.44 to 11.35, and debt to equity declined from 0.02 to 0.01.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 3/6/2020 due to a noticeable increase in the growth index, efficiency index and solvency index. Total capital increased 68.39% from $169.54M to $285.49M, the quick ratio increased from 7.44 to 11.35, and debt to equity declined from 0.02 to 0.01.
D
Sell
7/29/2019Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 7/29/2019 due to a major decline in the solvency index, total return index and growth index. Operating cash flow declined 43.12% from -$16.73M to -$23.94M, the quick ratio declined from 11.94 to 7.8, and EBIT declined 28.67% from -$22.02M to -$28.34M.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 7/29/2019 due to a major decline in the solvency index, total return index and growth index. Operating cash flow declined 43.12% from -$16.73M to -$23.94M, the quick ratio declined from 11.94 to 7.8, and EBIT declined 28.67% from -$22.02M to -$28.34M.
D
Sell
11/14/2018Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 11/14/2018 due to an increase in the valuation index, solvency index and growth index. The quick ratio increased from 7.22 to 16.19, earnings per share increased from -$1.305 to -$0.8656, and total revenue increased 33.19% from $3.22M to $4.29M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 11/14/2018 due to an increase in the valuation index, solvency index and growth index. The quick ratio increased from 7.22 to 16.19, earnings per share increased from -$1.305 to -$0.8656, and total revenue increased 33.19% from $3.22M to $4.29M.
D
Sell
5/10/2018Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 5/10/2018 due to a large decline in the total return index, growth index and efficiency index. Net income declined 440.35% from -$3.01M to -$16.25M, earnings per share declined from -$0.1581 to -$0.8031, and operating cash flow declined 58.66% from -$9.77M to -$15.5M.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 5/10/2018 due to a large decline in the total return index, growth index and efficiency index. Net income declined 440.35% from -$3.01M to -$16.25M, earnings per share declined from -$0.1581 to -$0.8031, and operating cash flow declined 58.66% from -$9.77M to -$15.5M.
D
Sell
3/12/2018Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 3/12/2018 due to a major increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.7066 to -$0.1581, the quick ratio increased from 5.54 to 9.06, and total revenue increased 24.66% from $2.66M to $3.32M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 3/12/2018 due to a major increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.7066 to -$0.1581, the quick ratio increased from 5.54 to 9.06, and total revenue increased 24.66% from $2.66M to $3.32M.
D
Sell
3/3/2017Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 3/3/2017 due to a noticeable decline in the growth index, valuation index and solvency index. Operating cash flow declined 40.37% from -$7.86M to -$11.04M, the quick ratio declined from 7.84 to 7.44, and EBIT declined 1.62% from -$11.68M to -$11.87M.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 3/3/2017 due to a noticeable decline in the growth index, valuation index and solvency index. Operating cash flow declined 40.37% from -$7.86M to -$11.04M, the quick ratio declined from 7.84 to 7.44, and EBIT declined 1.62% from -$11.68M to -$11.87M.
D
Sell
6/29/2016Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 6/29/2016 due to an increase in the total return index, growth index and volatility index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 6/29/2016 due to an increase in the total return index, growth index and volatility index.
D
Sell
4/26/2016Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 4/26/2016 due to a decline in the volatility index and valuation index.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D on 4/26/2016 due to a decline in the volatility index and valuation index.
D
Sell
4/11/2016Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 4/11/2016 due to an increase in the volatility index and valuation index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D from D- on 4/11/2016 due to an increase in the volatility index and valuation index.
D
Sell
3/11/2016Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D+ on 3/11/2016 due to a substantial decline in the total return index, volatility index and growth index. Earnings per share declined from -$0.3846 to -$0.4494, EBIT declined 13.3% from -$7.12M to -$8.07M, and operating cash flow declined 5.19% from -$5.19M to -$5.46M.
Assembly Biosciences, Inc. (ASMB) was downgraded to D- from D+ on 3/11/2016 due to a substantial decline in the total return index, volatility index and growth index. Earnings per share declined from -$0.3846 to -$0.4494, EBIT declined 13.3% from -$7.12M to -$8.07M, and operating cash flow declined 5.19% from -$5.19M to -$5.46M.
D
Sell
11/10/2015Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D+ from D on 11/10/2015 due to an increase in the efficiency index.
Assembly Biosciences, Inc. (ASMB) was upgraded to D+ from D on 11/10/2015 due to an increase in the efficiency index.
D
Sell
10/21/2015Downgrade
Assembly Biosciences, Inc. (ASMB) was downgraded to D from D+ on 10/21/2015 due to a substantial decline in the volatility index, total return index and efficiency index. Net income declined 2.83% from -$7.15M to -$6.94M.
Assembly Biosciences, Inc. (ASMB) was downgraded to D from D+ on 10/21/2015 due to a substantial decline in the volatility index, total return index and efficiency index. Net income declined 2.83% from -$7.15M to -$6.94M.
D
Sell
5/8/2015Upgraded
Assembly Biosciences, Inc. (ASMB) was upgraded to D+ from D on 5/8/2015 due to a significant increase in the volatility index, total return index and growth index. EBIT increased 23.9% from -$5.81M to -$7.2M, earnings per share increased from -$0.5903 to -$0.64, and operating cash flow increased 2.24% from -$3.59M to -$3.67M.
Assembly Biosciences, Inc. (ASMB) was upgraded to D+ from D on 5/8/2015 due to a significant increase in the volatility index, total return index and growth index. EBIT increased 23.9% from -$5.81M to -$7.2M, earnings per share increased from -$0.5903 to -$0.64, and operating cash flow increased 2.24% from -$3.59M to -$3.67M.
NASDAQ
04/11/2025 4:00PM Eastern
Quotes delayed
